I while back I had made some references to ACEL and noone responded. I was re-reading a recent article on Onconase(their flagship RNA-based product currently in Phase IIIb clinical trials) and noticed something quite interesting.
Here is the excerpt:
"The Department of Cancer Control in Turkey will use a marker that has been developed, similar to PSA for Prostate Cancer, that will allow them to identify Mesothelioma in it's early stages and then monitor the levels of the marker after treatment with Onconase thus providing the desired proof of concept.
The development of markers similar to PSA and this new one being tested in Turkey for Meso are being developed for all forms of Cancer. Once available, Onconase could be in widespread use for the prevention on cancer in high risk groups".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.